Hubert Birner Insider Profile
4 Followers
Hubert Birner, Director, Ten Percent Owner at Protara Therapeutics, holds ― shares in Argos Therapeutics (Ticker: ARGSQ), holds 1.94M shares in Protara Therapeutics (Ticker: TARA), holds 1.67M shares in Horizon Therapeutics (Ticker: HZNP).
Hubert Birner's Trading History
| ARGSQArgos Therapeutics | Jan 04, 2017 | ― | Uninformative Buy | ― | ― | |
| TARAProtara Therapeutics | Oct 29, 2014 | Director, Ten Percent Owner | Informative Buy | 535.95K | $4.92M | |
| HZNPHorizon Therapeutics | Aug 04, 2011 | ― | Informative Buy | 1.92M | $194.47M |
You May Also Like
Hubert Birner insider profile FAQ
What is the percentage of profitable transactions made by Hubert Birner?
The percentage of profitable transactions made by Hubert Birner is 100%.
What is the average return per transaction made by Hubert Birner?
The average return per transaction made by Hubert Birner is 26.60%.
What stocks does Hubert Birner hold?
Hubert Birner holds: TARA, ARGSQ, HZNP stocks.
What was Hubert Birner's most profitable transaction?
Hubert Birner’s most profitable transaction was an Informative Buy of TARA stock on October 29, 2014. The return on the trade was 37.20%.
What is Hubert Birner's role in Protara Therapeutics?
Hubert Birner's role in Protara Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
